The Chinese healthcare industry has shown outstanding growth over the last few years. Ever since the reform process, the investment activities in Chinese healthcare sector have grown at a healthy growth rate and this has helped the sector posting better results than expected. As per our research on the sector titled -China Healthcare Sector Analysis-, healthcare spending in China is projected to grow at a CAGR of around 18% during 2010-2012.
In present industry scenario, most of the healthcare services in China are presently provided by the government and expansion of these services after reform has created huge demand of drugs, medical devices and equipments in the country. Moreover, the demand in other associated segments like health insurance and healthcare IT services has also increased robustly. In this regard, the report provides a complete analysis of the impact of healthcare reform on the Chinese healthcare market. We expect that the demand in emerging segments like OTC drugs and biopharmaceuticals will also post healthy growth rates.
The report studies the Chinese healthcare market by diving it into three major segments i.e. pharmaceuticals, medical devices and health services. Out of these three segments medical device market is expected to outperform the other segments. Our research gives a complete and statistical overview on all the three segments. Besides this, the report thoroughly studies the competitive landscape of the industry and provides valuable information to clients.